Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets

v3.24.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2023
Dec. 31, 2022
Current Assets    
Cash and cash equivalents $ 2,815 $ 6,888
Trading marketable securities 7,611 9,150
Available-for-sale securities (amortized cost of $0 and $1,502, respectively) 0 1,495
Prepaid expenses and other current assets 554 789
Total Current Assets 10,980 18,322
Operating lease right-of-use assets 21 60
Intangible asset 2,039 2,039
Other assets 3 3
TOTAL ASSETS 13,043 20,424
Current Liabilities    
Accounts payable and accrued liabilities 1,238 905
Due to related parties 30 53
Operating lease liabilities - current portion 23 40
Total Current Liabilities 1,291 998
Operating lease liabilities 0 23
TOTAL LIABILITIES 1,291 1,021
STOCKHOLDERS' EQUITY    
Preferred Stock, par value $0.001, 416,667 shares authorized, 0 shares issued and outstanding as of December 31, 2023 and December 31, 2022 0 0
Common Stock, par value $0.001, 50,000,000 shares authorized, as of December 31, 2023 and December 31, 2022 3,188,959 and 2,855,688 shares issued and outstanding as of December 31, 2023 and December 31, 2022 3 3
Additional paid-in capital 52,262 50,675
Accumulated deficit (40,310) (31,021)
Accumulated other comprehensive loss (203) (254)
TOTAL STOCKHOLDERS' EQUITY 11,752 19,403
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY $ 13,043 $ 20,424